DexCom Share Holder Equity 2012-2025 | DXCM
DexCom share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- DexCom share holder equity for the quarter ending September 30, 2025 was $2.726B, a 37.75% increase year-over-year.
- DexCom share holder equity for 2024 was $2.103B, a 1.64% increase from 2023.
- DexCom share holder equity for 2023 was $2.069B, a 2.96% decline from 2022.
- DexCom share holder equity for 2022 was $2.132B, a 4.39% increase from 2021.
|
DexCom Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $2,103 |
| 2023 | $2,069 |
| 2022 | $2,132 |
| 2021 | $2,042 |
| 2020 | $1,827 |
| 2019 | $883 |
| 2018 | $663 |
| 2017 | $419 |
| 2016 | $284 |
| 2015 | $221 |
| 2014 | $140 |
| 2013 | $84 |
| 2012 | $77 |
| 2011 | $105 |
|
DexCom Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $2,726 |
| 2025-06-30 | $2,573 |
| 2025-03-31 | $2,267 |
| 2024-12-31 | $2,103 |
| 2024-09-30 | $1,979 |
| 2024-06-30 | $2,434 |
| 2024-03-31 | $2,247 |
| 2023-12-31 | $2,069 |
| 2023-09-30 | $2,268 |
| 2023-06-30 | $2,100 |
| 2023-03-31 | $2,233 |
| 2022-12-31 | $2,132 |
| 2022-09-30 | $1,825 |
| 2022-06-30 | $2,256 |
| 2022-03-31 | $2,189 |
| 2021-12-31 | $2,042 |
| 2021-09-30 | $2,136 |
| 2021-06-30 | $1,998 |
| 2021-03-31 | $1,903 |
| 2020-12-31 | $1,827 |
| 2020-09-30 | $1,499 |
| 2020-06-30 | $1,354 |
| 2020-03-31 | $935 |
| 2019-12-31 | $883 |
| 2019-09-30 | $764 |
| 2019-06-30 | $688 |
| 2019-03-31 | $669 |
| 2018-12-31 | $663 |
| 2018-09-30 | $562 |
| 2018-06-30 | $482 |
| 2018-03-31 | $422 |
| 2017-12-31 | $419 |
| 2017-09-30 | $384 |
| 2017-06-30 | $354 |
| 2017-03-31 | $278 |
| 2016-12-31 | $284 |
| 2016-09-30 | $262 |
| 2016-06-30 | $246 |
| 2016-03-31 | $231 |
| 2015-12-31 | $221 |
| 2015-09-30 | $193 |
| 2015-06-30 | $171 |
| 2015-03-31 | $149 |
| 2014-12-31 | $140 |
| 2014-09-30 | $115 |
| 2014-06-30 | $100 |
| 2014-03-31 | $90 |
| 2013-12-31 | $84 |
| 2013-09-30 | $75 |
| 2013-06-30 | $72 |
| 2013-03-31 | $74 |
| 2012-12-31 | $77 |
| 2012-09-30 | $80 |
| 2012-06-30 | $91 |
| 2012-03-31 | $100 |
| 2011-12-31 | $105 |
| 2011-09-30 | $113 |
| 2011-06-30 | $122 |
| 2011-03-31 | $53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $27.586B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.567B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $189.075B | 73.97 |
| IDEXX Laboratories (IDXX) | United States | $54.780B | 54.40 |
| Edwards Lifesciences (EW) | United States | $48.432B | 32.47 |
| IQVIA Holdings (IQV) | United States | $39.797B | 22.19 |
| Alcon (ALC) | Switzerland | $39.104B | 26.35 |
| Mettler-Toledo (MTD) | United States | $28.673B | 33.55 |
| STERIS (STE) | Ireland | $25.321B | 26.14 |
| Waters (WAT) | United States | $22.858B | 30.23 |
| Coloplast (CLPBY) | Denmark | $18.998B | 32.42 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.345B | 0.00 |
| Penumbra (PEN) | United States | $13.920B | 97.92 |
| Globus Medical (GMED) | United States | $12.440B | 26.11 |
| Masimo (MASI) | United States | $7.665B | 24.56 |
| Glaukos (GKOS) | United States | $7.090B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.188B | 19.66 |
| TransMedics (TMDX) | United States | $4.850B | 57.46 |
| Teleflex (TFX) | United States | $4.434B | 7.07 |
| LivaNova (LIVN) | United Kingdom | $3.436B | 18.56 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Integer Holdings (ITGR) | United States | $2.984B | 14.01 |
| Alphatec Holdings (ATEC) | United States | $2.548B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.400B | 22.45 |
| Artivion (AORT) | United States | $2.061B | 94.59 |
| UFP Technologies (UFPT) | United States | $2.023B | 26.71 |
| Nihon Kohden (NHNKY) | Japan | $1.955B | 17.07 |
| PROCEPT BioRobotics (PRCT) | United States | $1.694B | 0.00 |
| AxoGen (AXGN) | United States | $1.470B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.389B | 0.00 |
| IRadimed (IRMD) | United States | $1.310B | 62.41 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.937B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.935B | 5.07 |
| Beta Bionics (BBNX) | United States | $0.811B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.671B | 38.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.550B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.548B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.540B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.463B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.458B | 12.63 |
| AngioDynamics (ANGO) | United States | $0.427B | 0.00 |
| RxSight (RXST) | United States | $0.397B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.360B | 59.94 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.237B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.195B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.126B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Venus Concept (VERO) | Canada | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.15 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |